New developments in the treatment of gastroparesis and functional dyspepsia

Current Opinion in Pharmacology
J Tack, Michael Camilleri

Abstract

Functional dyspepsia (FD) and gastroparesis are frequent causes of upper gastrointestinal symptoms such as postprandial fullness, early satiation, epigastric pain or burning, upper abdominal bloating, bothersome belching, nausea and vomiting. The underlying pathophysiological mechanisms are heterogeneous and involved mechanisms such as abnormal gastric motility (accommodation, emptying), visceral hypersensitivity, low grade mucosal inflammation and cellular changes in enteric nerves, muscle or interstitial cells of Cajal. Patient-reported outcomes for evaluating treatment efficacy in these conditions were recently developed and validated. Prokinetic agents, which enhance gastric motility, are used for treating both gastroparesis and FD. In FD, besides acid suppressive therapy and Helicobacter pylori eradication, neuromodulators and drugs that enhance gastric accommodation can be applied. In gastroparesis, anti-emetics may also provide symptom relief. Novel approaches under evaluation in these conditions are the fundus relaxing agents acotiamide and buspirone and the antidepressant mirtazapine in FD. For gastroparesis, recently studied agents include the prokinetic ghrelin agonist relamorelin, the prokinetic serotonergic agents ...Continue Reading

Citations

Dec 7, 2018·Current Opinion in Endocrinology, Diabetes, and Obesity·H Christian Weber
Oct 1, 2019·Expert Opinion on Investigational Drugs·Jan TackFlorencia Carbone
Nov 13, 2019·The American Journal of Gastroenterology·Vineet Gudsoorkar, Eamonn M M Quigley
Jan 5, 2020·Expert Opinion on Pharmacotherapy·A VandenbergheJ Tack
Jul 3, 2020·The Keio Journal of Medicine·Hidekazu Suzuki
Jul 18, 2019·Internal Medicine Journal·Kieran J Longley, Vincent Ho
Sep 17, 2020·Annals of the New York Academy of Sciences·Carmelo ScarpignatoRichard H Hunt
Feb 19, 2019·World Journal of Gastroenterology : WJG·Tilemachos KoutouratsasMaria Gazouli
Mar 30, 2019·Alimentary Pharmacology & Therapeutics·Imke MasuyJan Tack
Feb 8, 2019·The American Journal of Gastroenterology·Jan TackFlorencia Carbone
Aug 8, 2019·Expert Opinion on Pharmacotherapy·M Louai Manini, Michael Camilleri
Apr 8, 2020·Frontiers in Psychiatry·Karen Van den HouteJan Tack
Apr 21, 2020·ACG Case Reports Journal·Mark Radetic, Scott Gabbard
Jul 18, 2020·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·Helen Burton MurrayHenry P Parkman
Jul 22, 2020·Drugs·Gregory S Sayuk, C Prakash Gyawali
Jun 2, 2020·World Journal of Gastroenterology : WJG·Yu GuoJiande Dz Chen
Feb 2, 2019·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·Karen Van den HouteJan Tack
Jun 28, 2019·Therapeutic Advances in Gastroenterology·Theresa MeldgaardAsbjørn Mohr Drewes
Oct 8, 2020·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·Nick GoelenPieter Janssen
Dec 8, 2020·Psychosomatic Medicine·Daniel B MaselliMichael Camilleri
Oct 27, 2020·The Journal of International Medical Research·Kuang-Yu WeiShih-Hua Lin
Dec 8, 2020·Evidence-based Complementary and Alternative Medicine : ECAM·Chun WangZhi-Jian Li
Feb 24, 2021·Gastroenterology·Jan TackMichael Horowitz
Dec 22, 2020·Hepatobiliary & Pancreatic Diseases International : HBPD INT·Yu-Ling SunJian Li
May 4, 2021·United European Gastroenterology Journal·Jolien ScholUNKNOWN ESNM Gastroparesis Consensus Group
May 5, 2021·The American Journal of Gastroenterology·Emidio ScarpelliniJan Tack
Mar 23, 2021·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Florencia CarboneJan Tack
Aug 3, 2021·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·Liz Febo-RodriguezRobert J Shulman
Aug 15, 2021·Journal of Diabetes and Its Complications·R J JallehC K Rayner
Aug 17, 2021·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·Jolien ScholUNKNOWN ESNM Gastroparesis Consensus Group
Dec 21, 2019·The Lancet. Gastroenterology & Hepatology·Neha R SantucciMiranda A van Tilburg
Sep 30, 2021·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·Lucas WautersFrank Zerbib
Jul 14, 2021·The Journal of Pharmacology and Experimental Therapeutics·Roger L WhitingJeffrey R Jasper

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Related Papers

Current Opinion in Gastroenterology
J Tack, Florencia Carbone
Current Gastroenterology Reports
J TackB DeMarchi
© 2022 Meta ULC. All rights reserved